Cat. No. | Product name | CAS No. | Purity | Chemical Structure |
---|---|---|---|---|
T78424 | CH3OCO-D-CHA-Gly-Arg-pNA acetate | 80895-10-9 | 98% |
|
CH3OCO-D-CHA-Gly-Arg-pNA acetate serves as a chromogenic substrate for Factor Xa, as documented in sources [1] [2]. | ||||
T79847 | Frunexian | 1803270-60-1 | 98% |
|
Frunexian (EP-7041) is a selective and potent inhibitor of coagulation factor XI/activated factor XI, specifically targeting XIa. It demonstrates antithrombotic ... | ||||
T80095 | D-Pro-Phe-Arg-Chloromethylketone | 88546-74-1 | 98% |
|
D-Pro-Phe-Arg-Chloromethylketone, an inhibitor of coagulation factor XII and plasma kallikrein, is significant in the regulation of thrombosis and inflammation [... | ||||
T82585 | Denecimig | 2488745-86-2 | 98% |
Denecimig
|
Denecimig (Mim8), a novel bispecific human antibody mimetic of activated coagulation factor VIII, possesses both anti-FIXa and anti-FX arms. This compound robust... | ||||
T12736 | Rivaroxaban-d4 | 1132681-38-9 | 98% |
|
Rivaroxaban D4 is a deuterium labeled Rivaroxaban. Rivaroxaban is a highly potent,selective and direct inhibitor of Factor Xa (FXa)(IC50:0.7 nM; Ki:0.4 nM). | ||||
T12782 | RWJ-445167 | 226566-43-4 | 98% |
|
RWJ-445167 is a thrombin and factor Xa dual inhibitor(Ki of 4.0 nM and 230 nM, respectively), with potent antithrombotic activity. | ||||
T19488 | O-Desmethyl apixaban sulfate sodium | T19488 | 98% |
|
O-Desmethyl apixaban sulfate sodium inhibits factor X (FXa) with a Ki of 58 μM,and is a major circulating metabolite of Apixaban in humans. | ||||
T6531 | Heparin sodium salt | 9041-08-1 | BR |
|
Heparin sodium is a sulfated polysaccharide, which belongs to the family of glycosaminoglycans. It is utilized as an anticoagulant and interacted with diverse pr... | ||||
T0775 | Coumarin | 91-64-5 | 99.96% |
|
Coumarin is a chemical compound/poison found in many plants, notably in high concentration in the tonka bean, woodruff, and bison grass. It has clinical value as... | ||||
T2368 | Edoxaban Tosylate Monohydrate | 1229194-11-9 | 99.86% |
|
Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical development for stroke prevention. | ||||
T1184 | Rivaroxaban | 366789-02-8 | 99.69% |
|
Rivaroxaban (BAY 59-7939) is an orally bioavailable oxazolidinone derivative and direct inhibitor of the coagulation factor Xa with anticoagulant activity. Upon ... | ||||
T0372 | Gabexate mesylate | 56974-61-9 | 99.64% |
|
Gabexate mesylate (FOY) is a serine proteinase inhibitor used therapeutically in the treatment of pancreatitis, disseminated intravascular coagulation (DIC), and... | ||||
T67853 | Rivaroxaban Impurity | 1151893-81-0 | 99.61% |
|
Rivaroxaban Impurity (Rivaroxaban-10) is a potent Blood-coagulation factor Xa inhibitor, IC50= 66 nM. | ||||
T0642 | 2-Methoxyphenothiazine | 1771-18-2 | 99.56% |
|
2-Methoxy Phenothiazine is light yellow or light gray solid. | ||||
T66256 | Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate | 503614-91-3 | 99.55% |
|
Ethyl 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylate has an inhibitory effect on coagula... | ||||
T27318 | Fidexaban | 183305-24-0 | 99.42% |
|
Fidexaban (CI1031) is a novel, potent, selective and orally active factor Xa inhibitor that has demonstrated antithrombotic activity in a variety of assays | ||||
T31206 | Darexaban | 365462-23-3 | 98.81% |
|
Darexaban (Tanexaban, YM-150) is a direct inhibitor of Factor Xa.Darexaban and Darexaban glucuronide selectively and competitively inhibit FXA and inhibit prothr... | ||||
T4980 | Betrixaban maleate | 936539-80-9 | 98.81% |
|
Betrixaban maleate is a non-vitamin K oral anticoagulant whose action is driven by the competitive and reversible inhibition of the factor Xa. | ||||
T20454 | 4-Chlorophenylurea | 140-38-5 | 98.69% |
|
4-Chlorophenylurea (NSC-12971) is a novel orally bioavailable inhibitor of factor Xa. | ||||
T68092 | Letaxaban | 870262-90-1 | 98.68% |
|
Letaxaban (TAK-442) is a small molecule Xa factor inhibitor that can be used to study polar coronary syndromes and thrombotic blockages. |